Close Menu

SAN FRANCISCO – Roche and Illumina said at the JP Morgan Healthcare Conference here on Monday that they have formed a partnership focused on driving the adoption of next-generation sequencing assays for oncology.

Under the 15-year, non-exclusive agreement with Roche, Illumina will grant Roche rights to develop and distribute in vitro diagnostic tests on Illumina's NextSeq 550Dx System, as well as on its future portfolio of Dx-branded sequencing systems, including the forthcoming NovaSeqDx.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A federal judge has ruled that drug companies, device manufacturers, and universities need to provide missing clinical data from hundreds of trials to a federal website, ScienceInsider reports.

A genetic analysis suggests red pandas might actually belong to two different species, New Scientist reports.

NPR reports that the US Centers for Disease Control and Prevention has fixed the problem with some of its SARS-CoV-2 testing kits.

In Nature this week: epigenetic factors that prevent healthy aging and more.